Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.

Mark L Brantly; L Terry Spencer; Margaret Humphries; Thomas J Conlon; Carolyn T Spencer; Amy Poirier; Wendy Garlington; Dawn Baker; Sihong Song; Kenneth I Berns

doi:10.1089/hum.2006.17.1177

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.

Identifier:nobleid.org/w1/20260515/EDC2AC2C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EDC2AC2C.svg?ark=w1%2F20260515%2FEDC2AC2C)](https://nobleid.org/work/w1/20260515/EDC2AC2C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults.

Identifier:nobleid.org/w1/20260515/EDC2AC2C

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EDC2AC2C.svg?ark=w1%2F20260515%2FEDC2AC2C)](https://nobleid.org/work/w1/20260515/EDC2AC2C)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work